Kiniksa Pharmaceuticals International, plc (KNSA) Gross profit 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual gross profit history from SEC filings — each fiscal year as reported.
$599.9MFY2025 · since FY2021: $29.4M → $599.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $599.9M | +65.6% |
| FY2024 | $362.3M | +53.0% |
| FY2023 | $236.9M | +20.1% |
| FY2022 | $197.3M | +570.0% |
| FY2021 | $29.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KNSA financial trends
KNSA RevenueKNSA Net incomeKNSA Net marginKNSA Gross marginKNSA Operating incomeKNSA Operating marginKNSA Operating cash flowKNSA Free cash flowKNSA Capital expendituresKNSA Return on equityKNSA Stock buybacksKNSA Dividends paidKNSA Total assetsKNSA Total liabilitiesKNSA Shareholders’ equityKNSA overview →